No products in the cart.
Retatrutide 20MG
A higher-dose research format of Retatrutide, this triple agonist peptide is studied for its enhanced efficacy in obesity, insulin resistance, and type 2 diabetes models. It supports advanced investigations into energy metabolism, glycemic control, and body fat reduction.
CURRENT BATCH: black lid
NET PEPTIDE CONTENT: 22.33Mg
13 in stock
C₂₂₁H₃₄₂N₄₆O₆₈ • ~4731.3 g/mol
For research use only.
Not for human or veterinary consumption.
Zenith Biopeptides assumes no liability for misuse or misapplication.
Not for human or veterinary consumption.
Zenith Biopeptides assumes no liability for misuse or misapplication.
All compounds are sold for laboratory research purposes only. Not for human or veterinary use. Buyer assumes full responsibility for lawful handling and research application. Zenith Biopeptides assumes no liability for misuse, misinterpretation, or unintended application
Product Care
Store in a cool, dry place. If reconstituted, keep at 36°F–46°F for best stability.
Product Care
Store in a cool, dry place. If reconstituted, keep at 36°F–46°F for best stability.
Related products
Cagrilitide 10MG
GLP- 1(S) 10MG
GHK-Cu 100MG
NAD+ 500mg
$50.00
Bacteriostatic Water 3ML
$5.00